| HOME >> BIOLOGY >> TECHNOLOGY |
Strategic acquisition to expand Cognizant's Life Sciences industry
offerings
TEANECK, N.J., Oct. 18 /PRNewswire-FirstCall/ -- Cognizant Technology Solutions Corporation (Nasdaq: CTSH), a leading provider of global IT and business process outsourcing services, today announced that it has signed a definitive agreement to acquire NJ-based marketRx, Inc., a leading provider of analytics and related software services to global Life Sciences companies in the pharmaceutical, biotechnology and medical devices segments. Cognizant will pay approximately $135 million in cash, which will be funded from current cash reserves.
This acquisition strengthens Cognizant's full-suite of offerings across all areas of the Life Sciences value chain - from Research & Development and Manufacturing to Sales & Marketing Operations. marketRx combines analytics, market research and software services to provide scalable, web-based solutions in three functional areas for Life Sciences companies: Sales Management & Operations, Brand Marketing & Product Management and Market Research. marketRx brings an impressive client base to Cognizant representing a total of 75 Life Sciences customers, including all of the largest 20 pharmaceutical companies and 4 out of the top 5 biotech companies.
"We welcome the marketRx employees and management team to Cognizant.
This acquisition expands our capabilities in the analytics segment and
broadens our service offerings for the Life Sciences industry, while
providing strong synergies with our existing Business Intelligence/Data
Warehousing and CRM services," said Francisco D'Souza, president and CEO,
Cognizant. "marketRx's proven global delivery model for analyt
'/>"/>
| SOURCE Cognizant Technology Solutions Corporation Copyright©2007 PR Newswire. All rights reserved |